• 

  December 17, 2025

  restor3d Completes First Clinical Cases of Fully Personalized 3D-Printed Knee Replacement System

  R.D. Solorzano

• 

  December 15, 2025

  Revalia Bio Secures ~$30M Government Contract to Build the Future of Human-First Drug Development

  R.D. Solorzano

• 

  December 11, 2025

  Inside Curi Bio’s Human Tissue Platforms: How They Work, What the $10M Series B Will Accelerate, and Why It Matters

  R.D. Solorzano

• 

  December 10, 2025

  Xeltis Secures Nearly €50M to Advance aXess Toward Market Entry as New Data Strengthen Clinical Profile

  R.D. Solorzano

• 

  November 28, 2025

  The Rise of the Tiger – Tiger BioSciences: Building a Fully Integrated Platform for Regenerative Medicine

  R.D. Solorzano

• 

  November 20, 2025

  InSphero Acquires Doppl SA, Expanding Its 3D Cell Culture Portfolio with the Gri3D® Platform

  R.D. Solorzano

• 

  November 17, 2025

  Tiger Aesthetics Invests in GenesisTissue to Advance Regenerative Breast Reconstruction

  R.D. Solorzano

• 

  November 11, 2025

  Lattice Medical Raises €43M to Transform Post-Cancer Reconstruction and Scale 3D Bioprinting in France

  R.D. Solorzano

• 

  October 14, 2025

  Why Vertex Is Staying the Course on VX-880 (Zimislecel) — Even as Novo Nordisk Pulls Back

  R.D. Solorzano

• 

  October 13, 2025

  Mytos Launches Automated CDMO to Scale Regenerative Cell Therapies

  R.D. Solorzano